Previous close | 2.0500 |
Open | 2.0500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 205.00 |
Expiry date | 2024-10-18 |
Day's range | 2.0500 - 2.0500 |
Contract range | N/A |
Volume | |
Open interest | 18 |
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackBuffett Praises Apple After Trimming It, Drops Paramount StakeFrance’s Macron Calls for Reset of Economic Ties With ChinaTreasury Rally Risks Running Into a $125 Billion Brick WallXi Begins Europe Tour in Paris as Macron Seeks to Reset TiesThe shares sur
Amgen ( NASDAQ:AMGN ) First Quarter 2024 Results Key Financial Results Revenue: US$7.45b (up 22% from 1Q 2023). Net...
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats